Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15964758rdf:typepubmed:Citationlld:pubmed
pubmed-article:15964758lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:15964758lifeskim:mentionsumls-concept:C0205549lld:lifeskim
pubmed-article:15964758lifeskim:mentionsumls-concept:C1516312lld:lifeskim
pubmed-article:15964758pubmed:issue15lld:pubmed
pubmed-article:15964758pubmed:dateCreated2005-7-8lld:pubmed
pubmed-article:15964758pubmed:abstractTextVarious heterocyclic hetero-methyl ketones of the 1-naphthyloxyacetyl-Val-Asp backbone have been prepared. A study of their structure-activity relationship (SAR) related to caspase-1, -3, -6, and -8 is reported. Their efficacy in a cellular model of cell death is also discussed. Potent broad-spectrum caspase inhibitors have been identified.lld:pubmed
pubmed-article:15964758pubmed:languageenglld:pubmed
pubmed-article:15964758pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:citationSubsetIMlld:pubmed
pubmed-article:15964758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15964758pubmed:statusMEDLINElld:pubmed
pubmed-article:15964758pubmed:monthAuglld:pubmed
pubmed-article:15964758pubmed:issn0960-894Xlld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:ChenNingNlld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:GuXinXlld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:LintonSteven...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:KaranewskyDon...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:TernanskyRobe...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:WuJoe CJClld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:KodandapaniLa...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:DiazJose-Luis...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:TomaselliKevi...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:KalishVincent...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:MedunaSteven...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:RobinsonEdwar...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:UllmanBrett...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:SchmitzAlbert...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:AjaTeresaTlld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:HerrmannJulia...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:NalleyKipKlld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:RoggoSilvio...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:SayersRobert...lld:pubmed
pubmed-article:15964758pubmed:authorpubmed-author:KrebsJoseph...lld:pubmed
pubmed-article:15964758pubmed:issnTypePrintlld:pubmed
pubmed-article:15964758pubmed:day1lld:pubmed
pubmed-article:15964758pubmed:volume15lld:pubmed
pubmed-article:15964758pubmed:ownerNLMlld:pubmed
pubmed-article:15964758pubmed:authorsCompleteYlld:pubmed
pubmed-article:15964758pubmed:pagination3632-6lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:meshHeadingpubmed-meshheading:15964758...lld:pubmed
pubmed-article:15964758pubmed:year2005lld:pubmed
pubmed-article:15964758pubmed:articleTitleStructure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads.lld:pubmed
pubmed-article:15964758pubmed:affiliationIdun Pharmaceuticals Inc., 9380 Judicial Drive, San Diego, CA 92121, USA. bullman@idun.comlld:pubmed
pubmed-article:15964758pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:15964758lld:chembl